National mapping on carbapenemases in Spain. The CARBA-MAP study
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: MERCK SHARP & DOHME DE ESPAÑA SA
- Execution start: 15/10/2020
- End of execution: 30/09/2021
- IP: NATALIA CHUECA PORCUNA